Deutsche Bank’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,741
| Closed | -$81K | – | 4243 |
|
|
2022
Q1 | $81K | Sell |
6,741
-730
| -10% | -$8.77K | ﹤0.01% | 3605 |
|
|
2021
Q4 | $146K | Sell |
7,471
-46,460
| -86% | -$908K | ﹤0.01% | 3485 |
|
|
2021
Q3 | $1.4M | Sell |
53,931
-104,363
| -66% | -$2.71M | ﹤0.01% | 2384 |
|
|
2021
Q2 | $3.48M | Buy |
158,294
+151,878
| +2,367% | +$3.34M | ﹤0.01% | 1763 |
|
|
2021
Q1 | $150K | Buy |
6,416
+4,569
| +247% | +$107K | ﹤0.01% | 3738 |
|
|
2020
Q4 | $32K | Hold |
1,847
| – | – | ﹤0.01% | 4099 |
|
|
2020
Q3 | $30K | Buy |
+1,847
| New | +$30K | ﹤0.01% | 3975 |
|
|
2020
Q2 | – | Sell |
-159
| Closed | -$2K | – | 4333 |
|
|
2020
Q1 | $2K | Sell |
159
-979
| -86% | -$12.3K | ﹤0.01% | 4041 |
|
|
2019
Q4 | $12K | Buy |
1,138
+949
| +502% | +$10K | ﹤0.01% | 4251 |
|
|
2019
Q3 | $4K | Sell |
189
-77
| -29% | -$1.63K | ﹤0.01% | 4432 |
|
|
2019
Q2 | $5K | Sell |
266
-1,060
| -80% | -$19.9K | ﹤0.01% | 4672 |
|
|
2019
Q1 | $49K | Buy |
1,326
+14
| +1% | +$517 | ﹤0.01% | 4355 |
|
|
2018
Q4 | $59K | Sell |
1,312
-789
| -38% | -$35.5K | ﹤0.01% | 4207 |
|
|
2018
Q3 | $287K | Buy |
2,101
+279
| +15% | +$38.1K | ﹤0.01% | 3996 |
|
|
2018
Q2 | $859K | Buy |
1,822
+128
| +8% | +$60.3K | ﹤0.01% | 3494 |
|
|
2018
Q1 | $927K | Buy |
+1,694
| New | +$927K | ﹤0.01% | 3316 |
|
|
2017
Q3 | – | Sell |
-22
| Closed | -$2K | – | 4559 |
|
|
2017
Q2 | $2K | Buy |
+22
| New | +$2K | ﹤0.01% | 4386 |
|